Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder
Sponsor: Children's Hospital Medical Center, Cincinnati
A PHASE1 clinical study on Child Development Disorders, Pervasive, this trial is completed. The trial is conducted by Children's Hospital Medical Center, Cincinnati and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Dec 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .